Latest Bristol-Myers Squibb Stories
Pierre Fabre are thus reinforcing their oncology portfolio which already enjoys a combination of chemotherapies, monoclonal antibodies and immuno-conjugates assets at various development phases CASTRES,
SAN DIEGO, Feb. 10, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU report provide analysis of individual large cap companies, promising drug candidates in their late stage pipelines, competitive
SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr.
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's
CAMBRIDGE, Mass., Jan.
Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan.
- An imitative word; an onomatopoetic word.